In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide
Open Access
- 1 January 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (1) , 24-26
- https://doi.org/10.1128/aac.32.1.24
Abstract
Isolates of Streptococcus pneumoniae, Enterococcus faecalis, Enterococcus faecium, and coagulase-positive and -negative staphylococci were investigated for their abilities, in vitro, to develop resistance to LY146032. Exposure of the organisms to incremental concentrations of LY146032 resulted in MICs 8- to 32-fold higher than those for the original isolates. After three passages on antibiotic-free medium, the high MICs were maintained for the coagulase-negative staphylococci and pneumococci, with a twofold decrease observed for the enterococci and a fourfold decrease observed for Staphylococcus aureus. The frequency of spontaneous emergence of resistance was highest with S. pneumoniae (1.2 X 10(-6) at 16 times the original MIC) and lowest with S. aureus (7.0 X 10(-10) at 8 times the original MIC). For bacteria For bacteria surviving time-kill studies MICs were also higher than were those for the original isolates. Exposure to LY146032 in vitro selected for strains with decreased susceptibilities to the antimicrobial agent. However, the emergence of resistance in vivo is unpredictable and can be evaluated only after prolonged clinical use of the drug.This publication has 13 references indexed in Scilit:
- Emergence of Vancomycin Resistance in Coagulase-Negative StaphylococciNew England Journal of Medicine, 1987
- Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendationsAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteriaAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of LY146032 (Daptomycin), a new peptolideEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- TEICOPLANIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCIThe Lancet, 1987
- In vitro activity of LY146032 against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1986
- In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620Antimicrobial Agents and Chemotherapy, 1985
- Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agarAntimicrobial Agents and Chemotherapy, 1983
- STREPTOCOCCUS PNEUMONIÆ RESISTANT TO PENICILLIN AND CHLORAMPHENICOLThe Lancet, 1977